Targeting cell death in NAFLD: mechanisms and targeted therapies

Abstract excerpt

Nonalcoholic fatty liver disease (NAFLD) is a group of chronic liver disease which ranges from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) and is characterized by lipid accumulation, inflammation activation, fibrosis, and cell death. To date, a number of preclinical studies or clinical trials associated with therapies targeting fatty acid metabolism, inflammatory factors and liver fibrosis are...

Topics

Join the communities discussing this publication.

• Autophagy in Disease and Therapy
• Endoplasmic Reticulum Stress and Disease
• Liver Disease Diagnosis and Treatment